J&J wins FDA approval for diabetes combo; What do the FDA's social media guidelines mean for digital marketers?;

> The FDA has approved Johnson & Johnson's ($JNJ) diabetes combo of Invokana and metformin. Story

> Johnson & Johnson's ($JNJ) Janssen Pharmaceuticals has extended its partnership with NASCAR and will sponsor the first race in the Sprint Cup Series as part of its activities around National AFib Awareness Month. Story

> Janssen has launched an online mental health video series, Healthy Minds, that will focus on brain disorder research and treatment. Story

> Sanofi ($SNY) has launched an authorized generic of colorectal cancer drug Eloxatin. Release

> Vaccinemaker PaxVax has named Jonathan Klock as its North American sales and marketing VP and Jeremy Gowler as its VP of global marketing. Release

And Finally... What do the FDA's social media guidelines mean for SEO and digital marketers in the pharma industry? Blog

Suggested Articles

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Call it a fall sports bounce. TV ad spending bumped up in August with the partial return of professional sports, and that included pharma buyers.

GI cancers are stubborn, as plenty of oncology drugmakers know. But BMS' Opdivo has broken through with two potentially practice-changing trials.